Screener
Dyne Therapeutics, Inc. DYN Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total assets | $1,079,950 | $1,186,958 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | 10,781 | 8,082 |
| Accrued expenses and other current liabilities | 29,211 | 37,548 |
| Vendor financing arrangement | 6,224 | — |
| Lease liabilities | 5,033 | 4,995 |
| Total current liabilities | 51,249 | 50,625 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s accounts payable?
- Dyne Therapeutics, Inc. (DYN) reported accounts payable of $10.78M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s accounts payable changed year-over-year?
- Dyne Therapeutics, Inc.'s accounts payable increased by 53.6% year-over-year, from $7.02M to $10.78M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s accounts payable has grown at a 18.6% compound annual growth rate (CAGR), from $3.44M to $8.08M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Dyne Therapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude